×
About 27,902 results

ALLMedicine™ Epilepsy Center

Research & Reviews  12,687 results

Temporal Lobectomy: Does It Worsen or Improve Presurgical Psychiatric Disorders?
https://doi.org/10.1007/7854_2021_224 10.1016/j.eplepsyres.2019.106251
Current Topics in Behavioral Neurosciences; Pintor L

May 7th, 2021 - Temporal lobe epilepsy (TLE) is the type of epilepsy most frequently associated with psychiatric morbidity. Respective surgery for focal epilepsy remains the preferred treatment for medically resistant epilepsy. The aim of this chapter is to revie...

T cell numbers correlate with neuronal loss rather than with seizure activity in medial...
https://doi.org/10.1111/epi.16914
Epilepsia Tröscher AR, Sakaraki E et. al.

May 6th, 2021 - Medial temporal lobe epilepsy (MTLE) is a drug-resistant focal epilepsy that can be caused by a broad spectrum of different inciting events, including tumors, febrile seizures, and viral infections. In human epilepsy surgical resections as well as...

Cell death of hippocampal CA1 astrocytes during early epileptogenesis.
https://doi.org/10.1111/epi.16910
Epilepsia Wu Z, Deshpande T et. al.

May 6th, 2021 - Growing evidence suggests that dysfunctional astrocytes are crucial players in the development of mesial temporal lobe epilepsy (MTLE). Using a mouse model closely recapitulating key alterations of chronic human MTLE with hippocampal sclerosis, he...

Brain FDG-PET findings in glutamic acid decarboxylase antibody-associated epilepsy.
https://doi.org/10.1111/jon.12874
Journal of Neuroimaging : Official Journal of the America... Mongay-Ochoa N, Sala-Padró J et. al.

May 6th, 2021 - Glutamic acid decarboxylase antibodies (GAD-Ab) are sometimes associated with chronic drug-resistant focal epilepsy. Clinically, it may manifest as mesial temporal lobe epilepsy (mTLE), with GAD-Ab patients difficult to distinguish. Therefore, the...

Inhibition of hyperactivity of the dorsal raphe 5-HTergic neurons ameliorates hippocamp...
https://doi.org/10.1111/cns.13648
CNS Neuroscience & Therapeutics; Cheng H, Qi Y et. al.

May 6th, 2021 - Epilepsy, frequently comorbid with depression, easily develops drug resistance. Here, we investigated how dorsal raphe (DR) and its 5-HTergic neurons are implicated in epilepsy. In mouse hippocampal kindling model, using immunochemistry, calcium f...

see more →

Guidelines  23 results

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic d...
https://doi.org/10.1212/WNL.0000000000005756
Neurology Kanner AM, Ashman E et. al.

Jun 14th, 2018 - To update the 2004 American Academy of Neurology guideline for managing treatment-resistant (TR) epilepsy with second- and third-generation antiepileptic drugs (AEDs). 2004 criteria were used to systemically review literature (January 2003 to Nove...

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and ris...
https://doi.org/10.1212/WNL.0000000000003685
Neurology Harden C, Tomson T et. al.

Apr 25th, 2017 - To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. Systematic review of evidence; modified Grading Reco...

Cavernoma-related epilepsy: review and recommendations for management--report of the Su...
https://doi.org/10.1111/epi.12402
Epilepsia Rosenow F, Alonso-Vanegas MA et. al.

Oct 18th, 2013 - Cerebral cavernous malformations (CCMs) are well-defined, mostly singular lesions present in 0.4-0.9% of the population. Epileptic seizures are the most frequent symptom in patients with CCMs and have a great impact on social function and quality ...

Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Repo...
https://www.aesnet.org/sites/default/files/file_attach/Guidelines/Neurology-2013-Morris-1453-9.pdf
George L. Morris III

Aug 27th, 2013 - VNS may be considered for seizures in children, for LGS-associated seizures, and for improving mood in adults with epilepsy (Level C). VNS may be considered to have improved efficacy over time (Level C).

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review)...
https://doi.org/10.1111/j.1528-1167.2009.02129.x
Epilepsia Harden CL, Meador KJ et. al.

Jun 9th, 2009 - A committee assembled by the American Academy of Neurology (AAN) reassessed the evidence related to the care of women with epilepsy (WWE) during pregnancy, including antiepileptic drug (AED) teratogenicity and adverse perinatal outcomes. It is hig...

see more →

Drugs  987 results see all →

Clinicaltrials.gov  13,867 results

Temporal Lobectomy: Does It Worsen or Improve Presurgical Psychiatric Disorders?
https://doi.org/10.1007/7854_2021_224 10.1016/j.eplepsyres.2019.106251
Current Topics in Behavioral Neurosciences; Pintor L

May 7th, 2021 - Temporal lobe epilepsy (TLE) is the type of epilepsy most frequently associated with psychiatric morbidity. Respective surgery for focal epilepsy remains the preferred treatment for medically resistant epilepsy. The aim of this chapter is to revie...

T cell numbers correlate with neuronal loss rather than with seizure activity in medial...
https://doi.org/10.1111/epi.16914
Epilepsia Tröscher AR, Sakaraki E et. al.

May 6th, 2021 - Medial temporal lobe epilepsy (MTLE) is a drug-resistant focal epilepsy that can be caused by a broad spectrum of different inciting events, including tumors, febrile seizures, and viral infections. In human epilepsy surgical resections as well as...

Cell death of hippocampal CA1 astrocytes during early epileptogenesis.
https://doi.org/10.1111/epi.16910
Epilepsia Wu Z, Deshpande T et. al.

May 6th, 2021 - Growing evidence suggests that dysfunctional astrocytes are crucial players in the development of mesial temporal lobe epilepsy (MTLE). Using a mouse model closely recapitulating key alterations of chronic human MTLE with hippocampal sclerosis, he...

Brain FDG-PET findings in glutamic acid decarboxylase antibody-associated epilepsy.
https://doi.org/10.1111/jon.12874
Journal of Neuroimaging : Official Journal of the America... Mongay-Ochoa N, Sala-Padró J et. al.

May 6th, 2021 - Glutamic acid decarboxylase antibodies (GAD-Ab) are sometimes associated with chronic drug-resistant focal epilepsy. Clinically, it may manifest as mesial temporal lobe epilepsy (mTLE), with GAD-Ab patients difficult to distinguish. Therefore, the...

Inhibition of hyperactivity of the dorsal raphe 5-HTergic neurons ameliorates hippocamp...
https://doi.org/10.1111/cns.13648
CNS Neuroscience & Therapeutics; Cheng H, Qi Y et. al.

May 6th, 2021 - Epilepsy, frequently comorbid with depression, easily develops drug resistance. Here, we investigated how dorsal raphe (DR) and its 5-HTergic neurons are implicated in epilepsy. In mouse hippocampal kindling model, using immunochemistry, calcium f...

see more →

News  309 results

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning
https://www.medscape.com/viewarticle/946270

Feb 21st, 2021 - A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the ...

COVID-19's Global Impact on Epilepsy
https://www.medscape.com/viewarticle/943001

Dec 20th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Around the globe, the COVID-19 pandemic has placed an enormous strain on patients with epilepsy, new research shows. The pandemic also appears to ...

SUDEP May Explain 3% of All Sudden Deaths in Kids
https://www.medscape.com/viewarticle/942139

Dec 6th, 2020 - Sudden unexpected death in epilepsy (SUDEP) may explain 3% of all sudden deaths in children – a prevalence rate that is at least three times greater than previously reported estimates – new research shows Dr Vicky Whittemore Just a few years ago, ...

Why Are Cases of SUDEP Declining?
https://www.medscape.com/viewarticle/937275

Sep 22nd, 2020 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner. Today I have a special guest, Dr Daniel Friedman, professor of neurology at New York University medical school and the author of a paper ...

Why Are Cases of SUDEP Declining?
https://www.staging.medscape.com/viewarticle/937275

Sep 22nd, 2020 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner. Today I have a special guest, Dr Daniel Friedman, professor of neurology at New York University medical school and the author of a paper ...

see more →

Patient Education  29 results see all →